{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:12:18Z","timestamp":1773799938048,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T00:00:00Z","timestamp":1276128000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s11064-010-0217-0","type":"journal-article","created":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T10:47:34Z","timestamp":1276080454000},"page":"1575-1587","source":"Crossref","is-referenced-by-count":36,"title":["Liposomal-Glutathione Provides Maintenance of Intracellular Glutathione and Neuroprotection in Mesencephalic Neuronal Cells"],"prefix":"10.1007","volume":"35","author":[{"given":"Gail D.","family":"Zeevalk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura P.","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. T.","family":"Guilford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,10]]},"reference":[{"key":"217_CR1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0026-895X(25)13535-9","volume":"14","author":"DG Graham","year":"1978","unstructured":"Graham DG (1978) Oxidatve pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 14:633\u2013643","journal-title":"Mol Pharmacol"},{"key":"217_CR2","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2174\/0929867013372922","volume":"8","author":"LM Sayre","year":"2001","unstructured":"Sayre LM, Smith MA, Perry G (2001) Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr Med Chem 8:721\u2013738","journal-title":"Curr Med Chem"},{"key":"217_CR3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biopha.2003.11.004","volume":"58","author":"J Emerit","year":"2004","unstructured":"Emerit J, Edeas M, Bricaire F (2004) Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 58:39\u201346","journal-title":"Biomed Pharmacother"},{"key":"217_CR4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0304-3940(82)90390-1","volume":"33","author":"TL Perry","year":"1982","unstructured":"Perry TL, Godin DV, Hansen S (1982) Parkinson\u2019s disease: a disorder due to nigral glutathione deficiency? Neurosci Lett 33:305\u2013310","journal-title":"Neurosci Lett"},{"key":"217_CR5","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1002\/ana.410320714","volume":"32","author":"P Jenner","year":"1992","unstructured":"Jenner P, Dexter DT, Sian J, Schapira AHV, Marsden CD (1992) Oxidative stress as a cause of nigral cell death in Parkinson\u2019s disease and incidental lewy body disease. Ann Neurol 32:S82\u2013S87","journal-title":"Ann Neurol"},{"key":"217_CR6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1471-4159.1989.tb09150.x","volume":"52","author":"P Riederer","year":"1989","unstructured":"Riederer P, Sofie E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MBH (1989) Transition metals, ferritin, glutathione and ascorbic acid in Parkinsonian brains. J Neurochem 52:515\u2013520","journal-title":"J Neurochem"},{"key":"217_CR7","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1046\/j.1460-9568.2000.00229.x","volume":"12","author":"KQ Do","year":"2000","unstructured":"Do KQ, Trabesinger AH, Kirsten-Kruger M, Lauer CJ, Dydak U, Hell D, Holsboer F, Boesiger P, Cuenod M (2000) Schizophrenia: glutathione deficits in cerebrospinal fluid and prefrontal cortex in vivo. Eur J Neurosci 12:3721\u20133728","journal-title":"Eur J Neurosci"},{"key":"217_CR8","doi-asserted-by":"crossref","first-page":"16621","DOI":"10.1073\/pnas.0706778104","volume":"104","author":"R Gysin","year":"2000","unstructured":"Gysin R, Krafsik R, Sandell J, Bovet P, Chappuis C, Conus P, Deppen P, Preisig M, Ruiz V, Steullet P, Tosic M, Werge T, Cuenod M, Do KQ (2000) Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence. Proc Natl Acad Sci 104:16621\u201316626","journal-title":"Proc Natl Acad Sci"},{"key":"217_CR9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jns.2008.08.021","volume":"280","author":"DA Geier","year":"2009","unstructured":"Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Nataf R, Geier MR (2009) Biomarkers of environmental toxicity and susceptibility in autism. J Neurolog Sci 280:101\u2013108","journal-title":"J Neurolog Sci"},{"key":"217_CR10","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/ajcn\/80.6.1611","volume":"80","author":"SJ James","year":"2004","unstructured":"James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA (2004) Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutri 80:1611\u20131617","journal-title":"Am J Clin Nutri"},{"key":"217_CR11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1067\/mpd.2003.203","volume":"142","author":"A Pastore","year":"2003","unstructured":"Pastore A, Tozzi G, Gaeta LM, Giannotti A, Bertini E, Federici G, Digilio MC, Piemonte F (2003) Glutathione metabolism and antioxidant enzymes in children with Down syndrome. J Pediat 142:583\u2013585","journal-title":"J Pediat"},{"key":"217_CR12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.freeradbiomed.2007.06.014","volume":"43","author":"I Dalla-Donne","year":"2007","unstructured":"Dalla-Donne I, Rossi R, Giustarini D, Colombo R, Milzani A (2007) Glutathionylation in protein redox regulation. Free Rad Biol Med 43:883\u2013898","journal-title":"Free Rad Biol Med"},{"key":"217_CR13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/10715760500072172","volume":"39","author":"P Ghezzi","year":"2005","unstructured":"Ghezzi P (2005) Regulation of protein function by glutathionylation. Free Rad Res 39:573\u2013580","journal-title":"Free Rad Res"},{"key":"217_CR14","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.expneurol.2006.09.004","volume":"203","author":"GD Zeevalk","year":"2007","unstructured":"Zeevalk GD, Manzino L, Sonsalla PK, Bernard LP (2007) Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: relevance to Parkinson\u2019s disease. Exp Neur 203:512\u2013520","journal-title":"Exp Neur"},{"key":"217_CR15","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1471-4159.1982.tb12548.x","volume":"37","author":"LA Wade","year":"1981","unstructured":"Wade LA, Brady HM (1981) Cysteine and cystine transport at the blood-brain barrier. J Neurochem 37:730\u2013734","journal-title":"J Neurochem"},{"key":"217_CR16","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/j.1471-4159.1993.tb09803.x","volume":"61","author":"J Sagara","year":"1993","unstructured":"Sagara J, Miura K, Bannai S (1993) Maintenance of neuronal glutathione by glial cells. J Neurochem 61:1677\u20131684","journal-title":"J Neurochem"},{"key":"217_CR17","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1126\/science.2185543","volume":"248","author":"JW Olney","year":"1990","unstructured":"Olney JW, Zorumski C, Price MT, Labruyere J (1990) L-cysteine, a bicarbonate-sensitive endogenous excitotoxin. Science 248:596\u2013599","journal-title":"Science"},{"key":"217_CR18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0006-8993(95)01139-0","volume":"705","author":"M Puka-Sundvall","year":"1995","unstructured":"Puka-Sundvall M, Eriksson P, Nilsson M, Sandberg M, Lehmann A (1995) Neurotoxicity of cysteine: interaction with glutamate. Brain Res 705:65\u201370","journal-title":"Brain Res"},{"key":"217_CR19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/jnr.20107","volume":"76","author":"AM Munoz","year":"2004","unstructured":"Munoz AM, Rey P, Soto-Otero R, Guerra MJ, Labandeira-Garcia JL (2004) Systemic administration of N-acetylcysteine protects dopaminergic neurons against 6-hydroxydopamine-induced degeneration. J Neurosci Res 76:551\u2013562","journal-title":"J Neurosci Res"},{"key":"217_CR20","doi-asserted-by":"crossref","unstructured":"Sekhon B, Sekhon C, Khan M, Patel SJ, Singh I, Singh AK (2003) N-Acetyl cysteine protects against injury in a rat model of focal cerebral ischemia. Brain Res 971:1\u20138","DOI":"10.1016\/S0006-8993(03)02244-3"},{"key":"217_CR21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0954-6111(97)90052-4","volume":"91","author":"A Gillissen","year":"2006","unstructured":"Gillissen A, Joworska M, Orth M, Coffiner M, Maes P, App EM (2006) Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitro. Respir Med 91:159\u2013168","journal-title":"Respir Med"},{"key":"217_CR22","doi-asserted-by":"crossref","unstructured":"Janaky R, Ogita K, Pasqualotto BA, Bains JS, Oja SS, Yondea Y, Shaw CA, (1999) Glutathione and signal transduction in the mammalian CNS. J Neurochem 73:889\u2013902","DOI":"10.1046\/j.1471-4159.1999.0730889.x"},{"key":"217_CR23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0006-8993(98)01252-9","volume":"817","author":"R Regan","year":"1999","unstructured":"Regan R, Guo Y (1999) Extracellular reduced glutathioine increases neuronal vulnerability to combined chemical hypoxia and glucose deprivation. Brain Res 817:145\u2013150","journal-title":"Brain Res"},{"key":"217_CR24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0306-4522(98)00597-1","volume":"91","author":"RF Regan","year":"1999","unstructured":"Regan RF, Guo YP (1999) Potentiation of excitotoxic injury by high concentrations of extracellular reduced glutathione. Neuroscience 91:463\u2013470","journal-title":"Neuroscience"},{"key":"217_CR25","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.atherosclerosis.2007.05.012","volume":"195","author":"M Rosenblat","year":"2007","unstructured":"Rosenblat M, Volkova N, Coleman R, Aviram M (2007) Anti-oxidant and anti-artherogenic properties of liposomal glutathione: studies in vitro, and in the atherosclerotic apolipoprotein E-deficient mice. Atherosclerosis 195:e61\u2013e68","journal-title":"Atherosclerosis"},{"key":"217_CR26","doi-asserted-by":"crossref","first-page":"9207","DOI":"10.1523\/JNEUROSCI.20-24-09207.2000","volume":"20","author":"M Thiruchelvam","year":"2000","unstructured":"Thiruchelvam M, Richfield EK, Baggs RB, Tank AW, Cory-Slechta DA (2000) The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: Implications for Parkinson\u2019s disease. J Neurosci 20:9207\u20139214","journal-title":"J Neurosci"},{"key":"217_CR27","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.neuro.2006.07.009","volume":"27","author":"LM Domico","year":"2006","unstructured":"Domico LM, Zeevalk GD, Bernard LP, Cooper KR (2006) Acute neurotoxic effects of mancozeb and maneb in mesencephalic neuronal cultures are associated with mitochondrial dysfunction. NeuroToxicol 27:816\u2013825","journal-title":"NeuroToxicol"},{"key":"217_CR28","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.neuro.2007.04.008","volume":"28","author":"LM Domico","year":"2007","unstructured":"Domico LM, Cooper KR, Bernard LP, Zeevalk GD (2007) Reactive oxygen species generation by the ethylene-bis-dithiocarbamate (EBDC) fungicide mancozeb and its contribution to neuronal toxicity in mesencephalic cells. NeuroToxicol 28:1079\u20131091","journal-title":"NeuroToxicol"},{"key":"217_CR29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1023\/A:1027384416811","volume":"32","author":"TK Wood","year":"2003","unstructured":"Wood TK, Sullivan AM, McDermott KW (2003) Viability of dopaminergic neurons is influenced by serum and astroglial cells in vitro. J Neurocytol 32:97\u2013103","journal-title":"J Neurocytol"},{"key":"217_CR30","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1046\/j.1471-4159.1998.70041421.x","volume":"70","author":"GD Zeevalk","year":"1998","unstructured":"Zeevalk GD, Bernard LP, Nicklas WJ (1998) Role of oxidative stress and the glutathione system in loss of dopamine neurons due to impairment of energy metabolism. J Neurochem 70:1421\u20131430","journal-title":"J Neurochem"},{"key":"217_CR31","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1089\/ars.2005.7.662","volume":"7","author":"GD Zeevalk","year":"2005","unstructured":"Zeevalk GD, Bernard LP (2005) Energy status, ubiquitin proteasomal function and oxidative stress during chronic and acute complex I inhibition with rotenone in mesencephalic cells. Antioxid Redox Signal 7:662\u2013672","journal-title":"Antioxid Redox Signal"},{"key":"217_CR32","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1159\/000017342","volume":"20","author":"GD Zeevalk","year":"1998","unstructured":"Zeevalk GD, Bernard LP, Sinha C, Ehrhart J, Nicklas WJ (1998) Excitotoxicity and oxidative stress during inhibition of energy metabolism. Dev Neurosci 20:444\u2013453","journal-title":"Dev Neurosci"},{"key":"217_CR33","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/bi00054a021","volume":"32","author":"K-D Lee","year":"1993","unstructured":"Lee K-D, Nir S, Papahadjopoulos D (1993) Quantitative analysis of liposome-cell interactions in vitro: rate constants of binding and endocytosis with suspension and adherent J774 cells and human monocytes. Biochemistry 32:889\u2013899","journal-title":"Biochemistry"},{"key":"217_CR34","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1242\/jcs.113.9.1515","volume":"113","author":"JP Luzio","year":"2000","unstructured":"Luzio JP, Rous BA, Bright NA, Pryor PR, Mullock BM, Piper RC (2000) Lysosome-endosome fusion and lysosome biogenesis. J Cell Sci 113:1515\u20131524","journal-title":"J Cell Sci"},{"key":"217_CR35","doi-asserted-by":"crossref","first-page":"C182","DOI":"10.1152\/ajpcell.1989.257.2.C182","volume":"257","author":"AE Gibson","year":"1989","unstructured":"Gibson AE, Noel RJ, Herlihy JT, Ward WF (1989) Phenylarsine oxide inhibition of endocytosis: effects on asiolofetuin internalization, Am. J Physiol Cell Physiol 257:C182\u2013C184","journal-title":"J Physiol Cell Physiol"},{"key":"217_CR36","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1084\/jem.140.5.1364","volume":"140","author":"PJ Edelson","year":"1974","unstructured":"Edelson PJ, Cohn ZA (1974) Effects of concanavalin A on mouse peritoneal macrophages I. Stimulation of endocytic activity and inhibition of phago-lysosome formation. J Exp Med 140:1364\u20131386","journal-title":"J Exp Med"},{"key":"217_CR37","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.biopha.2008.01.017","volume":"62","author":"GD Zeevalk","year":"2008","unstructured":"Zeevalk GD, Razmpour R, Bernard LP (2008) Glutathione and Parkinson\u2019s disease: is this the elephant in the room? Biomed Pharmacother 62:236\u2013249","journal-title":"Biomed Pharmacother"},{"key":"217_CR38","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1212\/WNL.48.6.1583","volume":"48","author":"HH Liou","year":"1997","unstructured":"Liou HH, Tsai MC, Chen CJ, Jeng JS, Chang YC, Chen SY, Chen RC (1997) Environmental risk factors and Parkinson\u2019s disease: a case control study in Taiwan. Neurology 48:1583\u20131588","journal-title":"Neurology"},{"key":"217_CR39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5271\/sjweh.1394","volume":"20","author":"G Meco","year":"1994","unstructured":"Meco G, Bonifati V, Vanacore N, Fabrizio E (1994) Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate. Scan J Work Environ Health 20:301\u2013305","journal-title":"Scan J Work Environ Health"},{"key":"217_CR40","doi-asserted-by":"crossref","first-page":"22530","DOI":"10.1074\/jbc.M500417200","volume":"280","author":"M Thiruchelvam","year":"2005","unstructured":"Thiruchelvam M, Prokopenko O, Cory-Slechta DA, Richfield EK, Buckley B, Mirochnitchenko O (2005) Overexpression of superoxide dismutase or glutathione peroxidase protects against the paraquat plus maneb-induced Parkinson disease phenotype. J Biol Chem 280:22530\u201322539","journal-title":"J Biol Chem"},{"key":"217_CR41","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0301-0082(99)00060-X","volume":"62","author":"R Dringen","year":"2000","unstructured":"Dringen R (2000) Metabolism and functions of glutathione in brain. Prog Neurobiol 62:649\u2013671","journal-title":"Prog Neurobiol"},{"key":"217_CR42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1017\/S1740925X05000207","volume":"1","author":"A Byrd","year":"2004","unstructured":"Byrd A, Sikorska M, Walker PR, Sandhu JK (2004) Effects of glutathione depletion on the viability of human NT2-derived neuronal and astroglial cultures. Neuron Glia Biol 1:317\u2013326","journal-title":"Neuron Glia Biol"},{"key":"217_CR43","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1046\/j.1471-4159.1998.70041421.x","volume":"70","author":"GD Zeevalk","year":"1998","unstructured":"Zeevalk GD, Bernard L, Nicklas WJ (1998) The role of oxidative stress and the glutathione system in the loss of dopamine neurons due to impairment of energy metabolism. J Neurochem 70:1421\u20131430","journal-title":"J Neurochem"},{"key":"217_CR44","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0165-0173(97)00045-3","volume":"25","author":"JS Bains","year":"1997","unstructured":"Bains JS, Shaw CA (1997) Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res Rev 25:335\u2013358","journal-title":"Brain Res Rev"},{"key":"217_CR45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.bb.07.060178.002251","volume":"7","author":"RE Pagano","year":"1978","unstructured":"Pagano RE, Weinstein JN (1978) Interaction of liposomes with mammalian cells. Annu Rev Biophys Bioeng 7:435\u2013468","journal-title":"Annu Rev Biophys Bioeng"},{"key":"217_CR46","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/0958-1669(95)80115-4","volume":"6","author":"A Chonn","year":"1995","unstructured":"Chonn A, Cullis PR (1995) Recent advances in liposomal drug-delivery systems. Curr Opin Biotech 6:698\u2013708","journal-title":"Curr Opin Biotech"},{"key":"217_CR47","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1046\/j.1471-4159.1996.66051876.x","volume":"66","author":"J Sagara","year":"1996","unstructured":"Sagara J, Makino N, Bannai S (1996) Glutathione efflux from cultured astrocytes. J Neurochem 66:1876\u20131881","journal-title":"J Neurochem"},{"key":"217_CR48","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1023\/A:1027310328310","volume":"22","author":"R Dringen","year":"1997","unstructured":"Dringen R, Kranich O, Hamprecht B (1997) The gamma-glutamyl transpeptidase inhibitor acivicin preserves glutathione released by astroglial cells in culture. Neurochem Res 22:727\u2013733","journal-title":"Neurochem Res"},{"key":"217_CR49","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1042\/bj1900697","volume":"190","author":"H Tolleshaug","year":"1980","unstructured":"Tolleshaug H, Abdelnour M, Berg T (1980) Binding of concanavalin A to isolated hepatocytes and its effect on uptake and degradation of asialo-fetuin by the cells. Biochem J 190:697\u2013703","journal-title":"Biochem J"},{"key":"217_CR50","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0006-8993(01)02342-3","volume":"902","author":"G Shanker","year":"2001","unstructured":"Shanker G, Allen JW, Mutkus LA, Aschner M (2001) The uptake of cysteine in cultured primary astrocytes and neurons. Brain Res 902:156\u2013163","journal-title":"Brain Res"},{"key":"217_CR51","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1046\/j.1471-4159.2003.01630.x","volume":"84","author":"Y Chen","year":"2003","unstructured":"Chen Y, Swanson RA (2003) The glutamate transporters EAAT2 and EAAT3 mediate cysteine uptake in cortical neuron cultures. J Neurochem 84:1332\u20131339","journal-title":"J Neurochem"},{"key":"217_CR52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","volume":"22","author":"CW Olanow","year":"1999","unstructured":"Olanow CW, Tatton WG (1999) Etiology and pathogenesis of Parkinson\u2019s disease. Annu Rev Neurosci 22:123\u2013144","journal-title":"Annu Rev Neurosci"},{"key":"217_CR53","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jama.281.4.341","volume":"281","author":"CM Tanner","year":"1999","unstructured":"Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, Mayeux R, Langston JW (1999) Parkinson disease in twins: an etiologic study. JAMA 281:341\u2013346","journal-title":"JAMA"},{"key":"217_CR54","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1073\/pnas.88.11.4656","volume":"88","author":"J Martinsson","year":"1991","unstructured":"Martinsson J, Meister A (1991) Glutathione deficiency decreases tissue ascorbate levels in newborn rats: ascorbate spares glutathione and protects. Proc Natl Acad Sci 88:4656\u20134660","journal-title":"Proc Natl Acad Sci"},{"key":"217_CR55","first-page":"1159","volume":"20","author":"G Sechi","year":"1996","unstructured":"Sechi G, Deledda MG, Bua G, Satta WM, Deiana GA, Pes GM, Rosati G (1996) Reduced intravenous glutathione in the treatment of early Parkinson\u2019s disease. Psychopharmacol Biol Psychiat 20:1159\u20131170","journal-title":"Psychopharmacol Biol Psychiat"},{"key":"217_CR56","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/mds.22401","volume":"24","author":"RA Hauser","year":"2009","unstructured":"Hauser RA, Lyons KE, McClain T, Carter S, Perlmutter D (2009) Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson\u2019s disease. Mov Disord 24:979\u2013983","journal-title":"Mov Disord"},{"key":"217_CR57","doi-asserted-by":"crossref","unstructured":"Kannan R, Kuhlenkamp JF, Jeandidler E, Trinh H, Ookhetens M, Kkaplowitz N (1990) Evidence for carrier-mediated transport of glutathione across the blood brain barrier in the rat. J Clin Invest 85:2009\u20132013","DOI":"10.1172\/JCI114666"},{"key":"217_CR58","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1210\/endo-103-4-1297","volume":"103","author":"EM Cornford","year":"1978","unstructured":"Cornford EM, Braun LD, Crane PD, Oldendorf WH (1978) Blood-brain barrier restriction of peptides and the low uptake of enkephalins. Endocrinology 103:1297\u20131303","journal-title":"Endocrinology"},{"key":"217_CR59","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/ana.410360306","volume":"36","author":"J Sian","year":"1994","unstructured":"Sian J, Dexter DT, Lees AJ, Daniel S, Jenner P, Marsden CD (1994) Glutathione-related enzymes in brain in Parkinson\u2019s Disease. Ann Neurol 36:356\u2013361","journal-title":"Ann Neurol"},{"key":"217_CR60","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1523\/JNEUROSCI.19-02-00562.1999","volume":"19","author":"R Dringen","year":"1999","unstructured":"Dringen R, Pfeiffer B, Hamprecht B (1999) Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J Neurosci 19:562\u2013569","journal-title":"J Neurosci"},{"key":"217_CR61","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1212\/WNL.41.5_Suppl_2.50","volume":"41","author":"A Carlsson","year":"1991","unstructured":"Carlsson A, Fornstedt B (1991) Catechol metabolites in the cerebrospinal fluid as possible markers in the early diagnosis of Parkinson\u2019s disease. Neurology 41:50\u201352","journal-title":"Neurology"},{"key":"217_CR62","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF01276419","volume":"103","author":"FC Cheng","year":"1996","unstructured":"Cheng FC, Kuo JS, Chia LG, Dryhurst G (1996) Elevated 5-S-cysteinyldopamine\/homovanillic acid ratio and reduced homovanillic acid in cerebrospinal fluid: possible markers for and potential insights into the pathoetiology of Parkinson\u2019s disease. J Neural Transmission 103:433\u2013446","journal-title":"J Neural Transmission"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-010-0217-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-010-0217-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-010-0217-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T20:04:39Z","timestamp":1740168279000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-010-0217-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,10]]},"references-count":62,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["217"],"URL":"https:\/\/doi.org\/10.1007\/s11064-010-0217-0","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,10]]}}}